SalaryGuide
AboutPricingFor Employers

Marketing jobs

1 marketing jobs

Cosette Pharmaceuticals logo
2 weeks ago

Director, Brand Marketing

Cosette Pharmaceuticals

Bridgewater, NJ (Hybrid)Full time$169K/yr – $211K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

1 jobs
Cosette Pharmaceuticals logo

Director, Brand Marketing

Cosette Pharmaceuticals

Bridgewater, NJ (Hybrid)

$169K/yr - $211K/yrIn-houseFull-timeDirector/executive
2 weeks ago
Cosette Pharmaceuticals logo
Cosette Pharmaceuticals

Director, Brand Marketing

Bridgewater, NJ (Hybrid)

$169K/yr – $211K/yrDirector/ExecutiveFull time

Posted 2 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own branded launches and ongoing lifecycle, weaving KOL engagement, congress planning, and patient access into one joined plan while aligning Sales, Market Access, and Medical Affairs for compliant material that drives brand performance.

  • Brand Strategy and Launch: set annual plans, messaging, channel mix, KOL programs, and congress tactics for two brands.
  • Field Enablement and Cross-Functional Alignment: deliver sales-ready materials, training support, and ensure MLR compliant promo across teams.
  • Access, Compliance and Lifecycle: shape patient hub and caregiver messaging, referral pathways, and payer-informed strategies with Medical Affairs and Regulatory.

Job Description

Responsibilities

  • Develop and execute annual brand plans for Sympazan and Evoxac Oral Solution, including positioning, messaging, and channel strategy.
  • Lead pre-launch and launch execution for Evoxac Oral Solution, including HCP and patient education materials, KOL engagement, and congress strategy.
  • Partner closely with the Sales, Training & Operations to ensure approved marketing content supports field force training and readiness.
  • Support KOL identification, development, and congress planning.
  • Own patient support and hub program strategy for Sympazan, including caregiver-focused messaging and access support resources.
  • Develop referral-pathway messaging for Evoxac Oral Solution in coordination with rheumatology specialist audiences.
  • Manage brand budgets and forecasts for both brands and report performance against plan.
  • Ensure all promotional and non-promotional materials for both brands clear MLR/PRC review, including adherence to Sympazan's boxed warning requirements.
  • Represent both brands in cross-functional planning forums, including Sales, Market Access, and Medical Affairs.
  • Serve as a marketing partner to Sales leadership and field teams to ensure effective execution of brand strategies.
Cosette Pharmaceuticals logo

Cosette Pharmaceuticals

Cosette Pharmaceuticals, Inc. is a U.S.-based, fully integrated pharmaceutical company with a fast-growing portfolio of products in women’s health and dermatology. Cosette has a long history in quality manufacturing of complex dosage forms including topical creams, ointments, oral liquids/solutions and suppositories. Cosette has corporate and manufacturing facilities in New Jersey and North Carolina and is supported by 350+ dedicated team members across all functional areas. Cosette is backed by Avista Healthcare Partners, a healthcare focused private equity firm, and funds managed by Hamilton Lane, a private markets investment management firm (Nasdaq: HLNE).For complaints. adverse event and medical inquiries, Contact:Email: drugsafety@cosettepharma.comPhone: 1 800-922-1038For CDMO Inquiries, Contact:Email: cdmo@cosettepharma.com

Founded in 2018
Bridgewater, New Jersey, USA
247 employees (4 in marketing)
www.cosettepharma.com

Traffic Signals

Monthly Visitors
14.3K

Headcount Trend

Current headcount: ~247

Marketing Team

Marketing Roles Posted (Last 30 Days)
3

Funding

Last Raise
Secondary Market, 2 years ago

Funding History

  • Jul 2024
    Secondary Market
  • Jul 2024
    Debt Financing

Recent News

失眠新药,卷起来了
May 25, 2026 • phirda.com
Cosette Pharmaceuticals names Bell CCO (brands)
May 20, 2026 • ROI-NJ
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)
May 19, 2026 • Business Wire
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)
May 19, 2026 • BioSpace
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)
May 19, 2026 • Morningstar.com
Cosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel, Strengthening Leadership Team to Drive Accelerated Growth and Strategic Expansion
Apr 29, 2026 • BioSpace
Cosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel, Strengthening Leadership Team to Drive Accelerated Growth and Strategic Expansion
Apr 29, 2026 • Business Wire
Garda snaps up Assertio and chemo infection treatment Rolvedon in $125M deal
Apr 9, 2026 • FiercePharma
Cosette expands portfolio through Assertio product acquisitions
Apr 9, 2026 • Pharma Letter
Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio
Apr 8, 2026 • BioSpace
Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio
Apr 8, 2026 • PharmiWeb
超 8 亿患者!被忽视的潜在大药市场
Mar 17, 2026 • phirda.com
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therapy (CGT) exclusivity
Dec 16, 2025 • Business Wire
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therapy (CGT) exclusivity
Dec 16, 2025 • Yahoo Finance
Cosette, Mayne Pharma terminate $430M acquisition deal
Dec 16, 2025 • NJBIZ
Cosette Pharmaceuticals Announces the Approval and Launch...
Dec 16, 2025 • PharmiWeb
Termination of Proposed Acquisition of Mayne Pharma
Dec 12, 2025 • PharmiWeb
Mayne Pharma Ends Cosette Agreement After FIRB Concerns
Dec 11, 2025 • Kalkine Media
Termination of Proposed Acquisition of Mayne Pharma
Dec 11, 2025 • Business Wire
After blocked Mayne deal, Australia M&As set for higher reverse break fees
Nov 26, 2025 • Investing.com
Australian govt objects to Mayne Pharma takeover by Cosette
Nov 24, 2025 • Pharma Letter
Mayne Pharma Halted Amid Cosette Acquisition Bid
Nov 21, 2025 • Sharecafe
Mayne Pharma Halted Amid Cosette Acquisition Bid
Nov 21, 2025 • Finance News Network
Australia Blocks U.S.-Based Cosette’s $387.2 Million Takeover of Mayne Pharma
Nov 21, 2025 • The Wall Street Journal
Dow Jones Top Company Headlines at 5 AM ET: Paramount, Comcast and Netflix Submit Bids for Warner Bros. Discovery | Conglomerate ...
Nov 21, 2025 • Morningstar.com
Australian government rejects Cosette's proposed Mayne Pharma buyout, citing 'national interest'
Nov 21, 2025 • FiercePharma
Australia Blocks U.S.-Based Cosette’s $387.2 Million Takeover of Mayne Pharma
Nov 21, 2025 • WSJ.com: US Business
Australia Blocks U.S.-Based Cosette’s $387.2 Million Takeover of Mayne Pharma
Nov 20, 2025 • The Wall Street Journal
Mayne Pharma Faces Appeal Over Cosette Acquisition
Nov 10, 2025 • Sharecafe
Mayne Pharma Faces Legal Challenges in Acquisition by Cosette Pharmaceuticals
Nov 10, 2025 • The Globe and Mail
High bar for material adverse change in M&A: Lessons from the Mayne Pharma / Cosette decision
Oct 31, 2025 • Herbert Smith Freehills Kramer
Mayne Pharma Faces Scrutiny Over Cosette Acquisition
Oct 31, 2025 • Sharecafe
No easy exit: Key takeaways from the Cosette / Mayne Pharma decision
Oct 17, 2025 • Ashurst
Court blocks Cosette's attempt to drop $438 million Mayne deal; shares jump
Oct 16, 2025 • Reuters
Mayne Pharma Wins Court Case, Advances Acquisition Scheme with Cosette
Oct 16, 2025 • TipRanks
Court rules US giant can’t terminate Mayne Pharma takeover
Oct 15, 2025 • AFR
Cosette's attempt to drop $438 million Mayne Pharma deal denied by court
Oct 15, 2025 • Reuters
MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight
Jul 14, 2025 • PR Newswire
MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight
Jul 14, 2025 • PR Newswire UK
Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs
Jul 1, 2025 • BioSpace
Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs
Jun 30, 2025 • Business Wire
Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs | HLNE Stock News
Jun 30, 2025 • GuruFocus
Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs
Jun 30, 2025 • citybiz
Mayne Pharma Shareholders Approve Cosette Acquisition
Jun 18, 2025 • Finance News Network
Mayne Pharma Shareholders Approve Cosette Acquisition
Jun 18, 2025 • Sharecafe
Mayne Pharma Engages in Legal Battle with Cosette Over Scheme Termination
Jun 15, 2025 • TipRanks
Cosette Attempts to Terminate Mayne Pharma Deal
Jun 4, 2025 • Sharecafe
MYX ASX: Cosette terminates $672m Mayne Pharma deal as legal challenge looms
Jun 4, 2025 • AFR
Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal
May 21, 2025 • Reuters
Mayne hit by 'misleading' drug safety claims from the FDA ahead of $430M buyout
May 13, 2025 • FiercePharma
Cosette Pharmaceuticals inaugurates global business operations in India
May 12, 2025 • BioSpectrum India
$186.97 Bn Sleeping Aids Market Opportunities and Strategies to 2034, Driven by Rising Obesity, Aging Population, and E-Commerce Expansion
May 9, 2025 • Research and Markets
Global Vulvovaginal Candidiasis Treatment Market Outlook 2025-2034: Growth Drivers, Share, And Trends
Mar 28, 2025 • EIN Presswire
Metronidazole Global Market Report 2025: Explore Comprehensive Insights with Detailed Market Analysis
Mar 26, 2025 • EIN Presswire
Seborrheic Keratosis Treatment Market Size to be Worth US$ 4.5 Bn by 2035, Growing at CAGR of 5.8% |Transparency Market Research
Feb 28, 2025 • PharmiWeb.com
Cosette paying $430M for Mayne's women’s health, dermatology franchise
Feb 25, 2025 • BioWorld Online
Corrs advises Cosette on acquisition
Feb 25, 2025 • Solicitors Journal
Corrs advises Cosette on A$672 million acquisition of Mayne
Feb 25, 2025 • Corrs Chambers Westgarth
PE-backed Cosette Pharmaceuticals to acquire Mayne Pharma for $430m
Feb 25, 2025 • PE Hub
US pharma giant Cosette makes $672m bid for Mayne Pharma
Feb 21, 2025 • AFR
Cosette sets sights on women's healthcare stardom with $430M Mayne Pharma buy
Feb 21, 2025 • Fierce Pharma
Cosette Pharmaceuticals acquires Mayne Pharma for $672M
Feb 21, 2025 • ROI-NJ
Cosette Pharmaceuticals Acquires Mayne Pharma
Feb 21, 2025 • New Jersey Business Magazine
AstraZeneca builds in China as Cosette buys Mayne
Feb 21, 2025 • pharmaphorum
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
Feb 21, 2025 • BioSpace
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
Feb 20, 2025 • Business Wire
Cosette Pharmaceuticals Acquires Mayne Pharma
Feb 20, 2025 • citybiz
Cosette Pharmaceuticals Announces Acquisition Of Mayne Pharma, Transforming Company Into A Leader In Women’S Health And Dermatology
Feb 20, 2025 • TradingView
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
Feb 20, 2025 • Business Wire
Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations
Feb 10, 2025 • Business Wire
Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations
Feb 10, 2025 • FinancialContent
Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation
Feb 3, 2025 • Business Wire
Healthcare & Life Sciences Private Equity Deal Tracker: Hamilton Lane Acquires Stake in Avista-Backed Cosette Pharmaceuticals | McGuireWoods LLP
Jul 25, 2024 • JD Supra
Hamilton Lane’s Acquisition of Equity Interest in Cosette
Jul 25, 2024 • Global Legal Chronicle
Hamilton Lane acquires major stake in New Jersey-based Cosette Pharmaceuticals
Jul 18, 2024 • The Business Journals
Hamilton Lane acquires stake in Avista-backed specialty pharmaceutical firm Cosette
Jul 18, 2024 • PE Hub
Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market
Jul 11, 2024 • BioSpace
Cosette Pharmaceuticals, Inc. on LinkedIn: #healthcare #pharma #cdmo #ivrt #manufacturing #fdaapproval #r
Feb 22, 2024 • LinkedIn
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin ...
Feb 22, 2024 • Business Wire
Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
Jan 3, 2024 • Yahoo Finance
Avista-backed Cosette Pharmaceuticals acquires women’s sexual health brand Vyleesi
Jan 3, 2024 • PE Hub
Palatin Completes Sale of Vyleesi® to Cosette ...
Dec 21, 2023 • PR Newswire